Systemic Anaplastic Large Cell Lymphoma
📧 Sign up to get email alerts when something new happens for Systemic Anaplastic Large Cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-12-30Clinical Trial Update: A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib [Phase 4]
A Phase 4 trial evaluating Crizotinib for systemic ALK-positive anaplastic large cell lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2010-04-26Clinical Trial Update: MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma [Phase 2]
This Phase 2 trial evaluating MDX-060 in relapsed or refractory anaplastic large cell lymphoma (systemic and primary cutaneous) has been wit…